ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00181142
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : December 26, 2017
Sponsor:
Information provided by (Responsible Party):
Johns Hopkins University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2004
  Actual Study Completion Date : December 2004